Biomea Fusion Files 2025 Proxy Statement

Ticker: BMEA · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1840439

Biomea Fusion, Inc. DEF 14A Filing Summary
FieldDetail
CompanyBiomea Fusion, Inc. (BMEA)
Form TypeDEF 14A
Filed DateApr 28, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, annual-meeting

TL;DR

Biomea Fusion's proxy statement is out for the June 11 meeting - vote on directors & pay.

AI Summary

Biomea Fusion, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting on June 11, 2025. The filing details the company's governance and proposals for shareholder vote, including the election of directors and executive compensation. The company is based in Redwood City, CA, and operates in the pharmaceutical preparations sector.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership and voting matters, impacting their ability to influence corporate decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new material financial or operational information that would inherently increase risk.

Key Numbers

  • 20250611 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
  • 20250428 — Filing Date (The proxy statement was filed on this date.)

Key Players & Entities

  • Biomea Fusion, Inc. (company) — Registrant
  • 0001840439 (company) — Central Index Key
  • 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
  • 900 Middlefield Road, Redwood City, CA 94063 (company) — Business Address

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important matters such as the election of directors, executive compensation, and other corporate actions.

When is Biomea Fusion's annual meeting scheduled?

Biomea Fusion's annual meeting is scheduled for June 11, 2025.

What is Biomea Fusion's SIC code?

Biomea Fusion's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

Where is Biomea Fusion located?

Biomea Fusion, Inc. is located at 900 Middlefield Road, 4th Floor, Redwood City, CA 94063.

What type of proxy statement was filed?

A Definitive Proxy Statement was filed by Biomea Fusion, Inc.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Biomea Fusion, Inc. (BMEA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.